deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT01651351

GLASSIA Infusion Rate Study

A Phase 4 Double-Blind Study to Assess the Safety and Tolerability of Intravenous Administration of GLASSIA in Healthy Adult Volunteers

Sponsor: Baxalta now part of Shire

Conditions Alpha1-antitrypsin Deficiency Healthy Volunteers
Interventions Alpha1-proteinase inhibitor Placebo: Human albumin 2.5%
Updated 12 times since 2017 Last updated: May 3, 2021 Started: Jul 31, 2012 Primary completion: Jan 16, 2013 Completion: Jan 16, 2013
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Alpha1-antitrypsin Deficiency and Healthy Volunteers, this trial is completed. The trial is conducted by Baxalta now part of Shire and has accumulated 12 data snapshots since 2012. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Dec 2017 · 10 months · monthly snapshotCompleted~Dec 2017 – ~Mar 2018 · 3 months · monthly snapshotCompleted~Mar 2018 – ~Jun 2018 · 3 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jun 2021 · 5 months · monthly snapshotCompleted~Jun 2021 – ~Dec 2021 · 6 months · monthly snapshotCompleted~Dec 2021 – ~Dec 2022 · 12 months · monthly snapshotCompleted~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshotCompleted~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

12 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE4

  4. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE4

  5. Dec 2021 — Dec 2022 [monthly]

    Completed PHASE4

▶ Show 7 earlier versions

  1. Jun 2021 — Dec 2021 [monthly]

    Completed PHASE4

  2. Jan 2021 — Jun 2021 [monthly]

    Completed PHASE4

  3. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

  4. Mar 2018 — Jun 2018 [monthly]

    Completed PHASE4

  5. Dec 2017 — Mar 2018 [monthly]

    Completed PHASE4

  6. Feb 2017 — Dec 2017 [monthly]

    Completed PHASE4

  7. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE4

    First recorded

Jul 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Baxalta now part of Shire
Data source: Takeda

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations